Prolastin c 1,000 MG/20 ML VLS
Ended Awarded
- Contract number
- SPE2DX25F6AEB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $27,404
Award facts
- Contract value 100% obligated
- $27,403.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $27,403.64 for Prolastin C 1,000 mg/20 ml vials. The award, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. The contract is funded through the Defense Logistics Agency's Medical Supply Chain operations, which serves as the government's primary source for pharmaceutical and medical supply distribution to Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. Prolastin C, an alpha-1 proteinase inhibitor used to treat alpha-1 antitrypsin deficiency, represents one of the specialized pharmaceutical products within the company's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. As a consistent supplier to the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated capability in delivering critical medical products to military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DX25F6AEB?
SPE2DX25F6AEB was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 25, 2025.
How much is contract SPE2DX25F6AEB worth?
The government has obligated $27,404 on SPE2DX25F6AEB.
Is contract SPE2DX25F6AEB an order under another contract?
Yes. SPE2DX25F6AEB is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AEB competed?
The extent of competition for SPE2DX25F6AEB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award